Expression of disialoganglioside GD2 in breast cancer subtypes

Gaß P, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Völkl S, Mackensen A, Landgraf L, Schulz-Wendtland R, Farwick N, Roessig C, Beckmann M, Fasching P, Erber R (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 20-20

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Paul Gaß Department of Obstetrics and Gynaecology Hanna Hübner Professur für Experimentelle Tumorpathologie Matthias Rübner Department of Obstetrics and Gynaecology Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Simon Völkl Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Matthias Beckmann Lehrstuhl für Geburtshilfe und Frauenheilkunde Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe Ramona Erber Institute of Pathology

Involved external institutions

Universitätsklinikum Münster DE Germany (DE)

How to cite

APA:

Gaß, P., Kailayangiri, S., Hübner, H., Rübner, M., Hartmann, A., Häberle, L.,... Erber, R. (2022). Expression of disialoganglioside GD2 in breast cancer subtypes. In ONCOLOGY RESEARCH AND TREATMENT (pp. 20-20). BASEL: KARGER.

MLA:

Gaß, Paul, et al. "Expression of disialoganglioside GD2 in breast cancer subtypes." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 20-20.

BibTeX: Download